Banks That Once Fought Stablecoins Are Now Planning to Issue Their Own
CRCL shares fall after the WSJ reports that banks once opposed to stablecoins—such as JPMorgan and Bank of America—are now exploring their own.
NOTRELOAD AI
Palo Alto Networks’ $25 Billion Shopping Spree: The Deals It Sealed—and the Ones That Got Away
Nikesh Arora held talks to buy Okta and Datadog that fell through on price and interest.
Longtime D-Wave CFO Markovich Retires Effective September 2
Greg Golkov, SVP of Finance, named acting CFO as bookings surge.
Oracle’s Extreme Sell-Off Creates Buying Opportunity Ahead of Investor Day, Citi Says
Citi maintains Buy on Oracle with $330 target after extreme sell-off. AI demand and $85B contracts seen as key drivers ahead of Investor Day.
Cardiol Therapeutics: B. Riley Sees 450% Upside as Phase 3 MAVERIC Trial Nears Completion
B. Riley initiates Cardiol Therapeutics at Buy with an $11 target, citing a de-risked Phase 3 MAVERIC trial and strong cash runway.
Boston Scientific Faces Weeks-Long Disruption From Cyberattack as Analysts Eye Q3 Impact
Boston Scientific reports a cyberattack detected August 25, 2026, disrupting systems, delaying product shipments worldwide. Full scope still unknown.